Abstract
AbstractBackgroundLong-term outcomes after critical COVID-19 have not been sufficiently studied. This study aimed to describe changes in functional outcome and health-related quality of life (HRQoL) assessed at 3 and 12 months in a cohort of critically ill COVID-19 survivors. A secondary aim was to investigate factors associated with good functional outcome and HRQoL at 12 months.MethodsThis prospective multicentre cohort study included critically ill COVID-19 patients admitted to six intensive care units in Sweden between May 2020 and May 2021. Surviving patients were invited to face-to-face follow-ups at 3 and 12 months. A good functional outcome was a Glasgow outcome scale extended ≥7. HRQoL was assessed by the physical and mental component summary of the SF-36v2®, with T-scores ≥45 representing a good HRQoL. Factors associated with good functional outcome and HRQoL at 12 months were explored by multivariable logistic regression.ResultsA good functional outcome was found in 93/264 (35%) and 138/217 (64%) of survivors at 3 and 12 months, respectively. There was a significant improvement in the SF-36v2® Physical component summary (PCS) between 3 and 12 months (mean 40 versus 44, p<0.001). The SF-36v2® Mental component summary (MCS) was within the normal range at 3 months, with no significant change at 12 months (mean 46 versus 48, p=0.05). Older age was associated with a good functional outcome. Low clinical frailty and absence of diabetes mellitus were associated with a good physical HRQoL. A shorter duration of mechanical ventilation was associated with a good outcome for all three outcome measures.ConclusionBetween 3 and 12 months, functional outcome and physical aspects of HRQoL significantly improved, indicating continued recovery up to at least one year after critical COVID-19. Low frailty, less comorbidity, and shorter duration of mechanical ventilation were associated with better long-term outcomes, while old age was associated with better functional outcome.Study registrationClinicalTrials.govIdentifier:NCT04974775, registered April 28, 2020.
Publisher
Cold Spring Harbor Laboratory
Reference38 articles.
1. Christopher M Petrilli , Simon A Jones , Jie Yang , Harish Rajagopalan , Luke O’Donnell , Yelena Chernyak , Katie A Tobin , Robert J Cerfolio , Fritz Francois , and Leora I Horwitz . Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in new york city: prospective cohort study. bmj, 369, 2020.
2. Wen-Jun Tu , Yakun Liu , and Xianwei Zeng . Critical care capacity during the omicron wave of the covid-19 pandemic in china: far from enough. The Lancet Regional Health– Western Pacific, 31, 2023.
3. Clinical Spectrum — COVID-19 Treatment Guidelines — covid19treatmentguidelines.nih.gov. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/. [Accessed 23-04-2024].
4. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material
5. Epidemiology, clinical course, and outcomes of critically ill adults with covid-19 in new york city: a prospective cohort study;The lancet,2020